14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 224 days ( -9,900.00 % )
Last Price $0.0001 0 %
High/ Low $0.0001 - $0.0100 9,900.00%
Chg 7 Days N/A $0.0001 $0.0001
Chg 30 Days N/A $0.0001 $0.0001
Chg 12 mos -50.00 % $0.0002 $0.0001
Trend - 3 mos 190.61 % Width: 91.38 %
Trend - 12 mos 0.87 % Width: 13,780.08 %
Pred. range - 3 mos $0.0002 - $0.0005 136.60 % - 352.79 %
Pred. range - 12 mos $0.00000147 - $0.0002 -98.53 % - 103.44 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Buy Feb 22, 2024 - 49 days
Short/Long MA avg 3 mos Buy Feb 23, 2024 - 48 days
Short MA avg 12 mos Buy Feb 22, 2024 - 49 days
Long MA avg 12 mos Buy Feb 22, 2024 - 49 days
Short/Long MA avg 12 mos Buy Mar 05, 2024 - 41 days
Pivot Short Sell Apr 30, 2024 - 2 days
Bollinger Buy Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Kaleido Biosciences Inc.

Kaleido Biosciences. Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disea... KLDO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT